Top Dividend Stocks For 2019

tags:LFUS,SSBI,CEL,NYMT,

Nexeo Solutions (NASDAQ: NXEO) is one of 24 public companies in the “Chemicals & allied products” industry, but how does it contrast to its competitors? We will compare Nexeo Solutions to similar companies based on the strength of its profitability, earnings, dividends, risk, analyst recommendations, institutional ownership and valuation.

Risk & Volatility

Get Nexeo Solutions alerts:

Nexeo Solutions has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500. Comparatively, Nexeo Solutions’ competitors have a beta of 1.08, suggesting that their average stock price is 8% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Nexeo Solutions and its competitors, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexeo Solutions 0 2 2 0 2.50 Nexeo Solutions Competitors 106 481 714 27 2.50

Nexeo Solutions presently has a consensus target price of $11.17, suggesting a potential upside of 16.68%. As a group, “Chemicals & allied products” companies have a potential upside of 7.82%. Given Nexeo Solutions’ stronger consensus rating and higher possible upside, equities research analysts clearly believe Nexeo Solutions is more favorable than its competitors.

Top Dividend Stocks For 2019: Littelfuse Inc.(LFUS)

Advisors' Opinion:

• [By Joseph Griffin]

  SG Americas Securities LLC raised its position in Littelfuse, Inc. (NASDAQ:LFUS) by 72.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,391 shares of the technology company’s stock after purchasing an additional 1,843 shares during the period. SG Americas Securities LLC’s holdings in Littelfuse were worth $914,000 at the end of the most recent reporting period.

• [By Stephan Byrd]

  Littelfuse (NASDAQ: LFUS) and ABB Group (NYSE:ABB) are both computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

• [By Ethan Ryder]

  Littelfuse (NASDAQ:LFUS) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a report issued on Thursday.

Top Dividend Stocks For 2019: Summit State Bank(SSBI)

Advisors' Opinion:

• [By Max Byerly]

  ValuEngine upgraded shares of Summit State Bank (NASDAQ:SSBI) from a hold rating to a buy rating in a research note released on Saturday.

  Separately, TheStreet raised Summit State Bank from a c+ rating to a b rating in a report on Wednesday, February 14th.

Top Dividend Stocks For 2019: Cellcom Israel Ltd.(CEL)

Advisors' Opinion:

• [By Lisa Levin]

  Thursday afternoon, the telecommunication services shares surged 0.58 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 5 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 2.5 percent.

• [By Lisa Levin]

  Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday. Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday. Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday. Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday. Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading. Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday. Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral. Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018. Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading. Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading
• [By Ethan Ryder]

  Millicom (OTCMKTS: MIICF) and Cellcom Israel (NYSE:CEL) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Top Dividend Stocks For 2019: New York Mortgage Trust Inc.(NYMT)

Advisors' Opinion:

• [By Joseph Griffin]

  Shares of NY Mtg Tr Inc/SH (NASDAQ:NYMT) have earned an average recommendation of “Hold” from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $6.06.

GAIL Q1 PAT seen up 25.2% YoY to Rs. 569 cr: HDFC

HDFC has come out with its first quarter (April-June�� 18) earnings estimates for the Materials sector. The brokerage house expects GAIL to report net profit at Rs. 569 crore up 25.2% year-on-year (up 28.1% quarter-on-quarter).

Net Sales are expected to increase by 36.8 percent Y-o-Y (up 1.1 percent Q-o-Q) to Rs. 15,601 crore, according to HDFC.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 19.4 percent Y-o-Y (up 33.8 percent Q-o-Q) to Rs. 2,269 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More First Published on Jul 19, 2018 06:11 pm

J.C. Penney's New Brooklyn Store Is an Interesting Move

J.C. Penney (NYSE:JCP) has spent most of the past two years in defense mode. Comp sales growth has slowed to a crawl, and a combination of competitive pressures and inventory management missteps has pressured profitability despite the company's deep cost cuts.

In response to these headwinds, J.C. Penney closed about 140 stores last year, and has shuttered about 200 stores since the beginning of 2015. Nevertheless, the company plans to open at least one new store this year. Last week, J.C. Penney announced that it will open its second location in Brooklyn on Aug. 10 at the Kings Plaza Shopping Center. This store may enable the company to test new retail concepts that could help power a broader recovery.

A new store is set to open

Kings Plaza is the largest mall in Brooklyn. For many years, it was anchored by Macy's and Sears Holdings (NASDAQ: SHLD). However, in 2016, the Sears store fell victim to one of that chain's many rounds of downsizing.

Over the past two years, mall owner Macerich has been redeveloping the massive Sears store for a handful of somewhat smaller tenants. J.C. Penney will join Primark, Zara, and Burlington Stores as one of four major tenants replacing Sears.

J.C. Penney will be one of the new anchors of Kings Plaza in Brooklyn. Image source: J.C. Penney.

The Kings Plaza store opening will come nearly four years after J.C. Penney first entered the borough with a store at Brooklyn's Gateway Center. The Gateway Center store has been one of the chain's top performers since it opened, according to management. Thus, it's no surprise that J.C. Penney was eager to open another Brooklyn location, particularly because Kings Plaza is somewhat more accessible to public transit than the Gateway Center.

Making the most of a smaller space

One slightly unusual thing about the Kings Plaza store is its size: 75,000 square feet. That is significantly smaller than the company average of about 110,000 square feet. Many J.C. Penney stores are even larger than that. For example, the Gateway Center location has 124,000 square feet of space.

Despite the new location's small footprint, it will have room for two of the company's signature sales-driving attractions. First, there will be a 2,000-square-foot Sephora boutique in the center of the store, building on J.C. Penney's incredibly successful partnership with the beauty specialty retailer. Second, the store will feature a small-format appliance department.

J.C. Penney's management has indicated that Sephora and appliances are critical for boosting sales per square foot. Many of the J.C. Penney stores that closed last year were targeted because they were too small to support Sephora shops and appliance departments.

By contrast, it seems inevitable that J.C. Penney will devote a lot less space to apparel in its Kings Plaza store. This makes sense, given that J.C. Penney's apparel departments have been struggling with sales declines in recent years.

A learning opportunity

J.C. Penney currently has appliance showrooms in about 600 of its more than 860 stores. The company has a chance to gain market share in appliances over the next couple of years as Sears is closing full-line stores faster than ever. However, to capture the full sales opportunity, J.C. Penney would need to put appliance departments in even more of its stores: ideally all of them.

The main constraint is space. J.C. Penney has been working to create a viable small-format appliance showroom that it could install in smaller stores. The Kings Plaza location will test that concept and should provide insights on whether it makes sense to add appliances to some of J.C. Penney's other smaller stores. The company may also discover that its apparel departments can become more productive with less space and a more curated assortment.

If the new store is successful, it could also pave the way for further store openings in urban markets where 100,000-plus-square-foot spaces are hard to come by. Thus, J.C. Penney has a lot riding on its Kings Plaza store opening next month.

Why Twitter, Papa John's International, and Zogenix Jumped Today

Major benchmarks resumed climbing on Thursday, effectively recouping yesterday's losses as investors shifted their focus away from trade-war tensions and back toward the start of corporate earnings season.

But several individual stocks climbed more than most, including Twitter (NYSE:TWTR), Papa John's�International�(NASDAQ:PZZA), and Zogenix (NASDAQ:ZGNX). Here's why they did so well.

Image source: Twitter.

When account deletions are a�good�thing

Shares of Twitter jumped 3.2% after multiple analysts weighed in with positive notes on the social media leader.

The timing of the calls is no coincidence; Twitter stock plunged early this week�on reports that the company deleted over 70 million fake and suspicious accounts in May and June, spurring concerns over its growth and the overall size of its actual monthly active user base.

Today, however,�Goldman Sachs analyst Heath Terry reiterated his buy rating and increased his per-share price target on Twitter stock from $40 to $55 -- or a roughly 25% premium from yesterday's close -- arguing that Twitter's "information quality" initiatives have been well-received by advertisers and should drive incremental top-line growth.

Meanwhile, MKM Partners analyst Rob Sanderson voiced a similar sentiment and reiterated his own buy rating on Twitter stock.

Papa John's positive leadership change

Papa John's stock surged 11.1% today in the wake of the resignation of the pizza chain's founder, John Schnatter, as chairman of the board. Schnatter will remain on the company's board of directors, and Papa John's will appoint a new chairman in the coming weeks.

In most situations, such a prominent executive change wouldn't be considered a good thing. But shares fell yesterday after Forbes reported that Schnatter had used a racial slur during a conference call in May -- albeit in the context of criticizing KFC spokesman Colonel Sanders for using the term without facing public backlash. Still, Schnatter apologized for the incident this morning, calling his choice of language "inappropriate and hurtful."�

It certainly doesn't help that, only a few months ago, Schnatter stepped down as CEO of Papa John's after condemning NFL anthem protests and partly blaming the league for slowing sales at his namesake chain. The NFL ended its sponsorship with the company in response.

Zogenix positive trial results

Finally, shares of Zogenix jumped 20.7%�following the pharmaceutical company's announcement of encouraging top-line results from its second phase 3 clinical trial of ZX008, a drug candidate for the treatment of children and young adults with Dravet syndrome.

The study met its primary end point, with ZX008 achieving a 54.7% greater reduction in monthly convulsive seizures compared to a placebo. The study also met all key secondary endpoints, with ZX008 demonstrating a greater-than-50% reduction in seizure frequency and longest seizure-free intervals in patients as compared to those using placebo.

"These impressive study results show the significant impact the addition of ZX008 made in reducing the burden of convulsive seizures for patients who are not adequately controlled using stiripentol, the standard of care for the treatment of Dravet syndrome in Europe," stated Dr. Rima Nabbout, the principal investigator of the study. Nabbout further suggested that, if approved, ZX008 could be a "transformative treatment" for the syndrome, which has few available treatment options today.